$0.520000
-0.02-3.17%
At Close: -
$0.523900
0.00390.75%
After Hours: 4:26 PM EDT
15 minutes delayed
Comments
Loading...
Renovaro (NASDAQ:RENB) Stock Quotes, Forecast and News Summary
Renovaro Stock (NASDAQ: RENB) stock price, news, charts, stock research, profile.
| Open | $0.52 |
| Close | $0.52 |
| Volume / Avg. | 1.32M / 687.30K |
| Day Range | $0.45 - $0.53 |
| 52 Wk Range | 0.42 - 5.25 |
| Market Cap | $80.64M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 37 |
| Short Interest | 3.24% |
| Days to Cover | 20.85 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Renovaro Inc.
Sector
Health Care
Industry
Biotechnology
Renovaro Inc is a biopharmaceutical company. It is engaged in the research and development of pharma...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Renovaro (RENB) stock?
You can purchase shares of Renovaro (NASDAQ:RENB) through any online brokerage.
Who are Renovaro (RENB) competitors?
Other companies in Renovaro’s space includes: CytomX Therapeutics (NASDAQ:CTMX), Cellectar Biosciences (NASDAQ:CLRB), Armata Pharmaceuticals (AMEX:ARMP), OS Therapies (AMEX:OSTX) and Vistagen Therapeutics (NASDAQ:VTGN).
What is the forecast, or price target, for Renovaro (RENB) stock?
There is no analysis for Renovaro to provide a consensus price target.
What is the current price for Renovaro (RENB)?
The stock price for Renovaro (NASDAQ: RENB) is $0.5239 last updated September 20, 2024 at 4:26 PM EDT.
Does Renovaro (RENB) pay a dividend?
There are no upcoming dividends for Renovaro.
When is Renovaro (NASDAQ:RENB) reporting earnings?
Renovaro’s Q1 earnings are confirmed for Tuesday, November 12, 2024.
Is Renovaro (RENB) going to split?
There is no upcoming split for Renovaro.
What sector and industry does Renovaro (RENB) operate in?
Renovaro is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.